DK0655244T3 - Composition based on amino acids to treat infections - Google Patents

Composition based on amino acids to treat infections

Info

Publication number
DK0655244T3
DK0655244T3 DK94402420T DK94402420T DK0655244T3 DK 0655244 T3 DK0655244 T3 DK 0655244T3 DK 94402420 T DK94402420 T DK 94402420T DK 94402420 T DK94402420 T DK 94402420T DK 0655244 T3 DK0655244 T3 DK 0655244T3
Authority
DK
Denmark
Prior art keywords
cysteine
amino acids
proportion
composition based
treat infections
Prior art date
Application number
DK94402420T
Other languages
Danish (da)
Other versions
DK0655244T5 (en
Inventor
Maurice Arnal
Francis Rose
Denis Breuille
Christiane Obled
Original Assignee
Nestle Sa
Agronomique Inst Nat Rech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9452315&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0655244(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestle Sa, Agronomique Inst Nat Rech filed Critical Nestle Sa
Publication of DK0655244T3 publication Critical patent/DK0655244T3/en
Application granted granted Critical
Publication of DK0655244T5 publication Critical patent/DK0655244T5/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Amino acid-based composition intended for oral, enteral or parenteral administration, which contains, in a biologically and nutritionally acceptable medium, at least cysteine, free or in the form of a precursor, prodrug, protein or peptide hydrolysate, in a proportion of pharmacologically active cysteine greater than the proportion of cysteine present in a nutritional composition corresponding to the requirements of a healthy man, the proportion of cysteine being determined relative to the total quantity of amino acids present in the composition.
DK94402420T 1993-10-28 1994-10-27 Composition based on amino acids to treat infections DK0655244T5 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9312884A FR2711529B1 (en) 1993-10-28 1993-10-28 Composition based on amino acids intended for the treatment of an infection or an aggression causing an inflammatory reaction, in animals and in humans.

Publications (2)

Publication Number Publication Date
DK0655244T3 true DK0655244T3 (en) 2002-08-05
DK0655244T5 DK0655244T5 (en) 2008-10-13

Family

ID=9452315

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94402420T DK0655244T5 (en) 1993-10-28 1994-10-27 Composition based on amino acids to treat infections

Country Status (9)

Country Link
EP (1) EP0655244B2 (en)
KR (1) KR950010884A (en)
AT (1) ATE216234T1 (en)
CA (1) CA2134380C (en)
DE (1) DE69430416T3 (en)
DK (1) DK0655244T5 (en)
ES (1) ES2171439T5 (en)
FR (1) FR2711529B1 (en)
PT (1) PT655244E (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999038507A1 (en) * 1998-01-30 1999-08-05 David George Le Couteur Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation
CA2399063C (en) * 2000-02-04 2014-01-28 Societe Des Produits Nestle S.A. A method for maintaining or improving the synthesis of mucins
EP1302115A1 (en) * 2001-10-16 2003-04-16 Societe Des Produits Nestle S.A. Use of cystathionine
WO2005077400A1 (en) * 2004-02-12 2005-08-25 Campina Nederland Holding B.V. Cysteine rich peptides for improving thiol homeostasis
US20090209647A1 (en) * 2005-06-14 2009-08-20 Nestec S.A. Nutritional method
DE102006018293A1 (en) * 2006-04-20 2007-10-25 Fresenius Kabi Deutschland Gmbh Pediatric amino acid solution for parenteral nutrition
EP2165713B1 (en) 2008-09-19 2012-11-14 Nestec S.A. Whey and thymus function
WO2011021926A1 (en) * 2009-08-21 2011-02-24 N.V. Nutricia Regulating the amino acid pool used for the acute-phase protein synthesis
EP2444083A1 (en) 2010-10-21 2012-04-25 Nestec S.A. Cysteine and food intake

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2531204A1 (en) * 1975-07-12 1977-01-13 Fresenius Chem Pharm Ind L-AMINO ACID MIXTURES FOR PARENTERAL OR ORAL USE
DE2946563A1 (en) * 1979-11-17 1981-05-21 B. Braun Melsungen Ag, 3508 Melsungen Aminoacid parenteral infusion soln. - for hepatic coma treatment contg. relatively high concns. of arginine, ornithine, glutamic acid and aspartic acid
DE3026368A1 (en) * 1980-07-11 1982-02-18 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München NUTRITIONAL SOLUTION FOR COMPLETE PARENTERAL NUTRITION AND FOR ENHANCED ENERGY PRODUCTION
US4604286A (en) * 1984-09-17 1986-08-05 Daigo Nutritive Chemicals, Ltd. Infusion solution for parenteral nutrition
JPH01501706A (en) * 1986-10-24 1989-06-15 プリマー　カビ　ゲーエムベーハー　ウント　コ．カーゲー Amino acid preparation containing N,N'-bis-L-amino acid-L-cystine-peptide for oral and parenteral administration
SE8704217D0 (en) * 1987-10-29 1987-10-29 Vinnars Erik Ab AMINO ACID COMPOSITION FOR PARENTERAL NUTRITION
US5224409A (en) † 1991-03-19 1993-07-06 Ashlock Company Apparatus for producing helical slices
US5214062A (en) † 1992-04-08 1993-05-25 Clintec Nutrition Co. Method and composition for treating immune disorders, inflammation and chronic infections
AU6060694A (en) † 1993-05-10 1994-11-17 Transcend Therapeutics, Inc Method for treating acquired immune deficiency syndrome

Also Published As

Publication number Publication date
PT655244E (en) 2002-08-30
ATE216234T1 (en) 2002-05-15
EP0655244B1 (en) 2002-04-17
DE69430416D1 (en) 2002-05-23
EP0655244A1 (en) 1995-05-31
FR2711529A1 (en) 1995-05-05
EP0655244B2 (en) 2008-06-11
KR950010884A (en) 1995-05-15
CA2134380A1 (en) 1995-04-29
DE69430416T3 (en) 2009-01-22
CA2134380C (en) 2010-06-22
FR2711529B1 (en) 1996-07-05
ES2171439T3 (en) 2002-09-16
DK0655244T5 (en) 2008-10-13
DE69430416T2 (en) 2002-12-05
ES2171439T5 (en) 2008-12-01

Similar Documents

Publication Publication Date Title
DK2016950T3 (en) Pharmaceutical composition comprising an exendin-4 peptide
ATE402957T1 (en) LOW TOXICITY ANALOGUE OF HUMAN INTERFERON ALPHA
GEP20074123B (en) Amino acids with affinity for the alpha−2−delta−protein
DE69129248T2 (en) Peptides with endothelin antagonistic activity, their preparation and pharmaceutical compositions
ES2141229T3 (en) PHARMACEUTICAL PRODUCTS OF MODIFIED PROTEINS AND PEPTIDES.
DE59810596D1 (en) HUMANES, RECOMBINANT INTERFERON BETA WITH IMPROVED SOLUBILITY
DK0655244T5 (en) Composition based on amino acids to treat infections
AR015498A1 (en) TABLE EDULCORANT COMPOSITIONS.
MX9703642A (en) Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein.
GEP20063763B (en) Thrombopoietin Receptor Modulating Peptide
ATE62407T1 (en) TASTE COVERING COMPOSITIONS.
ATE69164T1 (en) MEDICATIONS FOR THE TREATMENT OF URAEMIA.
MY124560A (en) Amino acid compositions and use thereof in immunosuppression
ES2087337T3 (en) IMPLANT COMPOSITIONS CONTAINING A BIOLOGICALLY ACTIVE PROTEIN, PEPTIDE OR POLYPEPTIDE.
DE60001489T2 (en) PHARMACEUTICAL PREPARATION FOR THE INTRAVENOUS OR INTRAMUSCULAR ADMINISTRATION OF OCTREOTIDE
FI942938A (en) Soy protein or hydrolysates in pharmaceutical compositions for protection of bioactive peptides against enzymatic inactivation
EP1557466A4 (en) Tumor antigen protein and utilization thereof
AU3693097A (en) Derivatives of somatostatin, amino acids or oligopeptides and their combination useful for promoting body growth
FR2710244B3 (en) Dietetic composition based on essential amino acids.
SE9100284D0 (en) NOVEL PEPTIDE
IT1247493B (en) Salts with anti-inflammatory, analgesic and antipyretic activity and pharmaceutical compositions which contain them
ITMI931822A1 (en) PHARMACEUTICAL COMPOSITIONS BASED ON NIMESULIDE, ORAL ADMINISTRABLE, NON-GASTROLESIVE AND / OR CONTROLLED RELEASE
SE8700125L (en) SHORT PEPTIDES FOR TREATMENT OF PSORIASIS AND SCHIZOPHENRIA